<DOC>
	<DOC>NCT00219089</DOC>
	<brief_summary>To demonstrate the efficacy and safety of aliskiren given to patients with both hypertension and diabetes mellitus</brief_summary>
	<brief_title>A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>Inclusion Criteria Patients with essential hypertension Patients with a documented diagnosis of Type 1 or Type 2 diabetes mellitus. Patients who are eligible and able to participate in the study Exclusion Criteria Severe hypertension History or evidence of a secondary form of hypertension History of hypertensive encephalopathy or cerebrovascular accident. Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril</keyword>
</DOC>